CA2740256A1 - Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees - Google Patents

Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees Download PDF

Info

Publication number
CA2740256A1
CA2740256A1 CA2740256A CA2740256A CA2740256A1 CA 2740256 A1 CA2740256 A1 CA 2740256A1 CA 2740256 A CA2740256 A CA 2740256A CA 2740256 A CA2740256 A CA 2740256A CA 2740256 A1 CA2740256 A1 CA 2740256A1
Authority
CA
Canada
Prior art keywords
composition
hydrocodone
naltrexone
peptide
opioid substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2740256A
Other languages
English (en)
Inventor
Thomas Piccariello
Randal J. Kirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire LLC
Original Assignee
Shire LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire LLC filed Critical Shire LLC
Priority claimed from CA2477004A external-priority patent/CA2477004C/fr
Publication of CA2740256A1 publication Critical patent/CA2740256A1/fr
Abandoned legal-status Critical Current

Links

CA2740256A 2002-02-22 2003-02-24 Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees Abandoned CA2740256A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US35836802P 2002-02-22 2002-02-22
US60/358,368 2002-02-22
US36208202P 2002-03-07 2002-03-07
US60/362,082 2002-03-07
CA2477004A CA2477004C (fr) 2002-02-22 2003-02-24 Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees
PCT/US2003/005525 WO2003072046A2 (fr) 2002-02-22 2003-02-24 Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2477004A Division CA2477004C (fr) 2002-02-22 2003-02-24 Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees

Publications (1)

Publication Number Publication Date
CA2740256A1 true CA2740256A1 (fr) 2003-09-04

Family

ID=35931665

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2740256A Abandoned CA2740256A1 (fr) 2002-02-22 2003-02-24 Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees

Country Status (2)

Country Link
CN (1) CN100413533C (fr)
CA (1) CA2740256A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843696A (en) * 1972-09-05 1974-10-22 Syva Co Methadone analog compounds
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
US4025501A (en) * 1975-03-20 1977-05-24 Syva Company Polypeptide propoxyphene derivatives for immunoassay reagents

Also Published As

Publication number Publication date
CN100413533C (zh) 2008-08-27
CN1720059A (zh) 2006-01-11

Similar Documents

Publication Publication Date Title
CA2477004C (fr) Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees
JP4691500B2 (ja) 過剰摂取又は乱用を防止するための薬学組成物
US20100144645A1 (en) Compositions and methods for enhancing analgesic potency of covalently bound-compounds, attenuating its adverse side effects, and preventing their abuse
US7375082B2 (en) Abuse-resistant hydrocodone compounds
US7338939B2 (en) Abuse-resistant hydrocodone compounds
US20070060500A1 (en) Pharmaceutical compositions for prevention of overdose or abuse
US8343927B2 (en) Pharmaceutical compositions for prevention of overdose or abuse
US20070203055A1 (en) Compounds and compositions for prevention of overdose of oxycodone
KR20060073538A (ko) 남용 방지성 암페타민 화합물
WO2007120648A2 (fr) Composes oxycodone mono et di-substitues et compositions correspondantes
US7163918B2 (en) Iodothyronine compositions
US20070066537A1 (en) Compounds and compositions for prevention of overdose of oxycodone
CA2740256A1 (fr) Nouveaux composes pharmaceutiques a liberation prolongee destines a empecher la consommation abusive de substances controlees
ZA200602598B (en) Pharmaceutical compositions for prevention of overdose or abuse
WO2003072047A2 (fr) Compositions d'iodothyronine
EP2080511A2 (fr) Systèmes d'administration de principe actif et procédé pour la protection et l'administration de principes actifs

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20131115